QQQ   304.28 (+0.14%)
AAPL   122.94 (-0.11%)
MSFT   214.24 (-0.52%)
FB   281.85 (-1.97%)
GOOGL   1,821.84 (-0.17%)
AMZN   3,186.73 (-0.52%)
TSLA   593.38 (+4.32%)
NVDA   535.84 (-1.07%)
BABA   266.91 (+2.14%)
CGC   28.63 (+1.60%)
GE   10.60 (+1.63%)
MU   69.90 (+1.14%)
AMD   92.31 (-1.53%)
T   29.23 (+0.48%)
NIO   45.35 (-5.48%)
F   9.21 (+0.11%)
ACB   11.24 (+2.65%)
NFLX   497.52 (-1.16%)
BA   237.20 (+5.96%)
GILD   60.86 (-0.44%)
DIS   153.24 (-0.24%)
QQQ   304.28 (+0.14%)
AAPL   122.94 (-0.11%)
MSFT   214.24 (-0.52%)
FB   281.85 (-1.97%)
GOOGL   1,821.84 (-0.17%)
AMZN   3,186.73 (-0.52%)
TSLA   593.38 (+4.32%)
NVDA   535.84 (-1.07%)
BABA   266.91 (+2.14%)
CGC   28.63 (+1.60%)
GE   10.60 (+1.63%)
MU   69.90 (+1.14%)
AMD   92.31 (-1.53%)
T   29.23 (+0.48%)
NIO   45.35 (-5.48%)
F   9.21 (+0.11%)
ACB   11.24 (+2.65%)
NFLX   497.52 (-1.16%)
BA   237.20 (+5.96%)
GILD   60.86 (-0.44%)
DIS   153.24 (-0.24%)
QQQ   304.28 (+0.14%)
AAPL   122.94 (-0.11%)
MSFT   214.24 (-0.52%)
FB   281.85 (-1.97%)
GOOGL   1,821.84 (-0.17%)
AMZN   3,186.73 (-0.52%)
TSLA   593.38 (+4.32%)
NVDA   535.84 (-1.07%)
BABA   266.91 (+2.14%)
CGC   28.63 (+1.60%)
GE   10.60 (+1.63%)
MU   69.90 (+1.14%)
AMD   92.31 (-1.53%)
T   29.23 (+0.48%)
NIO   45.35 (-5.48%)
F   9.21 (+0.11%)
ACB   11.24 (+2.65%)
NFLX   497.52 (-1.16%)
BA   237.20 (+5.96%)
GILD   60.86 (-0.44%)
DIS   153.24 (-0.24%)
QQQ   304.28 (+0.14%)
AAPL   122.94 (-0.11%)
MSFT   214.24 (-0.52%)
FB   281.85 (-1.97%)
GOOGL   1,821.84 (-0.17%)
AMZN   3,186.73 (-0.52%)
TSLA   593.38 (+4.32%)
NVDA   535.84 (-1.07%)
BABA   266.91 (+2.14%)
CGC   28.63 (+1.60%)
GE   10.60 (+1.63%)
MU   69.90 (+1.14%)
AMD   92.31 (-1.53%)
T   29.23 (+0.48%)
NIO   45.35 (-5.48%)
F   9.21 (+0.11%)
ACB   11.24 (+2.65%)
NFLX   497.52 (-1.16%)
BA   237.20 (+5.96%)
GILD   60.86 (-0.44%)
DIS   153.24 (-0.24%)
Log in
NASDAQ:EDIT

Editas Medicine News Headlines

$33.23
+1.67 (+5.29 %)
(As of 12/3/2020 12:00 AM ET)
Add
Compare
Today's Range
$31.42
Now: $33.23
$34.29
50-Day Range
$27.69
MA: $30.74
$33.66
52-Week Range
$14.01
Now: $33.23
$39.96
Volume1.37 million shs
Average Volume954,528 shs
Market Capitalization$2.07 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.02

Headlines

Editas Medicine (NASDAQ EDIT) News Headlines Today

Source:
SourceHeadline
Editas Medicine (NASDAQ:EDIT) PT Lowered to $31.00Editas Medicine (NASDAQ:EDIT) PT Lowered to $31.00
marketbeat.com - October 13 at 9:05 AM
BidaskClub Lowers Editas Medicine (NASDAQ:EDIT) to SellBidaskClub Lowers Editas Medicine (NASDAQ:EDIT) to Sell
marketbeat.com - September 29 at 10:15 AM
Editas Medicine (NASDAQ:EDIT) Upgraded by BidaskClub to "Hold"Editas Medicine (NASDAQ:EDIT) Upgraded by BidaskClub to "Hold"
marketbeat.com - August 20 at 5:15 AM
Editas Medicine (NASDAQ:EDIT) Trading Up 5.3%Editas Medicine (NASDAQ:EDIT) Trading Up 5.3%
americanbankingnews.com - December 3 at 7:36 PM
Genetic Modification Therapies Market Research 2020: Global Size, Growth, Trends, Outlook and Future Scope AnalysisGenetic Modification Therapies Market Research 2020: Global Size, Growth, Trends, Outlook and Future Scope Analysis
marketwatch.com - December 3 at 3:57 PM
Editas Medicine (NASDAQ:EDIT) Trading 6.4% Higher Editas Medicine (NASDAQ:EDIT) Trading 6.4% Higher
americanbankingnews.com - November 27 at 7:12 PM
Editas Medicine (NASDAQ:EDIT) Trading Up 5.1%Editas Medicine (NASDAQ:EDIT) Trading Up 5.1%
americanbankingnews.com - November 13 at 8:02 PM
Morgan Stanley Cuts Editas Medicine (NASDAQ:EDIT) Price Target to $30.00Morgan Stanley Cuts Editas Medicine (NASDAQ:EDIT) Price Target to $30.00
americanbankingnews.com - November 11 at 12:14 PM
Editas Medicine Reports Inducement Grants to New Chief Medical OfficerEditas Medicine Reports Inducement Grants to New Chief Medical Officer
finance.yahoo.com - November 10 at 8:38 PM
The Editas Medicine, Inc. (NASDAQ:EDIT) Analysts Have Been Trimming Their Sales ForecastsThe Editas Medicine, Inc. (NASDAQ:EDIT) Analysts Have Been Trimming Their Sales Forecasts
nasdaq.com - November 10 at 10:37 AM
Editas Medicine, Inc. (NASDAQ:EDIT) Analysts Just Slashed Next Years Revenue Estimates By 20%Editas Medicine, Inc. (NASDAQ:EDIT) Analysts Just Slashed Next Year's Revenue Estimates By 20%
finance.yahoo.com - November 10 at 10:36 AM
Editas Medicine to Present at Barclays Gene Editing & Gene Therapy SummitEditas Medicine to Present at Barclays Gene Editing & Gene Therapy Summit
finance.yahoo.com - November 9 at 6:52 PM
Editas Medicine Appoints Lisa A. Michaels, M.D., as Chief Medical OfficerEditas Medicine Appoints Lisa A. Michaels, M.D., as Chief Medical Officer
finance.yahoo.com - November 9 at 1:34 PM
Editas Medicine, Inc. Just Reported A Surprise Profit And Analysts Updated Their EstimatesEditas Medicine, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates
nasdaq.com - November 7 at 12:54 PM
Editas Medicine, Inc. Beat Analyst Profit Forecasts, And Analysts Have New EstimatesEditas Medicine, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
finance.yahoo.com - November 7 at 12:54 PM
Editas Medicine, Inc. (EDIT) Q3 2020 Earnings Call TranscriptEditas Medicine, Inc. (EDIT) Q3 2020 Earnings Call Transcript
fool.com - November 6 at 3:48 PM
Editas (EDIT) Earnings Rise Y/Y in Q3, EDIT-101 in FocusEditas' (EDIT) Earnings Rise Y/Y in Q3, EDIT-101 in Focus
finance.yahoo.com - November 6 at 2:50 PM
Editas Medicine, Inc. (EDIT) CEO Cindy Collins on Q3 2020 Results - Earnings Call TranscriptEditas Medicine, Inc. (EDIT) CEO Cindy Collins on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 11:16 PM
Editas Medicine EPS beats by $0.78, beats on revenueEditas Medicine EPS beats by $0.78, beats on revenue
seekingalpha.com - November 5 at 6:15 PM
Editas Medicine Announces Third Quarter 2020 Results and UpdateEditas Medicine Announces Third Quarter 2020 Results and Update
finance.yahoo.com - November 5 at 6:15 PM
Editas Medicine, Inc. to Host Earnings CallEditas Medicine, Inc. to Host Earnings Call
finance.yahoo.com - November 5 at 6:15 PM
Editas Medicine (EDIT) Tops Q3 Earnings and Revenue EstimatesEditas Medicine (EDIT) Tops Q3 Earnings and Revenue Estimates
finance.yahoo.com - November 5 at 6:15 PM
December 24th Options Now Available For Editas MedicineDecember 24th Options Now Available For Editas Medicine
nasdaq.com - November 5 at 1:15 PM
Editas Medicine Q3 2020 Earnings PreviewEditas Medicine Q3 2020 Earnings Preview
seekingalpha.com - November 4 at 10:01 PM
Editas Medicine to Host Conference Call Discussing Third Quarter 2020 Results and Corporate UpdateEditas Medicine to Host Conference Call Discussing Third Quarter 2020 Results and Corporate Update
finance.yahoo.com - October 29 at 5:51 PM
Understanding Editas Medicines Unusual Options ActivityUnderstanding Editas Medicine's Unusual Options Activity
benzinga.com - October 23 at 7:41 PM
Understanding Editas Medicine's Unusual Options ActivityUnderstanding Editas Medicine's Unusual Options Activity
finance.yahoo.com - October 21 at 2:29 PM
Editas Medicine up 5% on favorable CRISPR/Cas9 patent rulingEditas Medicine up 5% on favorable CRISPR/Cas9 patent ruling
seekingalpha.com - September 11 at 9:10 AM
Editas Medicine Announces U.S. Patent and Trademark Office Grants the Broad Institute Priority Benefit in CRISPR InterferenceEditas Medicine Announces U.S. Patent and Trademark Office Grants the Broad Institute Priority Benefit in CRISPR Interference
finance.yahoo.com - September 11 at 9:10 AM
15.1%+ Growth for Gene Editing Services Market Size Raising to USD 9.55 Billion by 2025 | Size, Growth, Opportunity and Forecast to 202515.1%+ Growth for Gene Editing Services Market Size Raising to USD 9.55 Billion by 2025 | Size, Growth, Opportunity and Forecast to 2025
marketwatch.com - September 7 at 9:20 AM
Why Is Editas (EDIT) Down 17.3% Since Last Earnings Report?Why Is Editas (EDIT) Down 17.3% Since Last Earnings Report?
finance.yahoo.com - September 5 at 2:35 PM
Editas Medicine to Participate in Upcoming Investor ConferencesEditas Medicine to Participate in Upcoming Investor Conferences
finance.yahoo.com - September 4 at 8:27 AM
Interesting EDIT Put And Call Options For October 23rdInteresting EDIT Put And Call Options For October 23rd
nasdaq.com - September 3 at 12:19 PM
If You Had Bought Editas Medicine (NASDAQ:EDIT) Stock Three Years Ago, You Could Pocket A 65% Gain TodayIf You Had Bought Editas Medicine (NASDAQ:EDIT) Stock Three Years Ago, You Could Pocket A 65% Gain Today
finance.yahoo.com - August 26 at 3:09 PM
Editas SCD Candidate Gets FDAs Rare Pediatric Disease TagEditas' SCD Candidate Gets FDA's Rare Pediatric Disease Tag
nasdaq.com - August 25 at 1:55 PM
Editas' SCD Candidate Gets FDA's Rare Pediatric Disease TagEditas' SCD Candidate Gets FDA's Rare Pediatric Disease Tag
finance.yahoo.com - August 25 at 1:55 PM
Editas Scores Rare Disease Tag For EDIT-301 Sickle Cell TreatmentEditas Scores Rare Disease Tag For EDIT-301 Sickle Cell Treatment
finance.yahoo.com - August 25 at 8:54 AM
Editas Medicine receives RPD designation for EDIT-301Editas Medicine receives RPD designation for EDIT-301
seekingalpha.com - August 24 at 12:48 PM
Editas Medicine nabs rare pediatric disease tag for sickle cell candidateEditas Medicine nabs rare pediatric disease tag for sickle cell candidate
seekingalpha.com - August 24 at 12:48 PM
Editas Medicine Receives Rare Pediatric Disease Designation for EDIT-301 for the Treatment of Sickle Cell DiseaseEditas Medicine Receives Rare Pediatric Disease Designation for EDIT-301 for the Treatment of Sickle Cell Disease
finance.yahoo.com - August 24 at 12:47 PM
First Week of EDIT October 16th Options TradingFirst Week of EDIT October 16th Options Trading
nasdaq.com - August 21 at 2:39 PM
Editas (EDIT) Earnings Beat in Q2, Revenues Improve Y/YEditas' (EDIT) Earnings Beat in Q2, Revenues Improve Y/Y
finance.yahoo.com - August 10 at 8:40 PM
Editas' (EDIT) Earnings Beat in Q2, Revenues Improve Y/YEditas' (EDIT) Earnings Beat in Q2, Revenues Improve Y/Y
finance.yahoo.com - August 10 at 3:39 PM
Editas Medicine, Inc. (EDIT) CEO Cindy Collins on Q2 2020 Results - Earnings Call TranscriptEditas Medicine, Inc. (EDIT) CEO Cindy Collins on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 7 at 1:04 AM
Editas Medicine Regains Full Global Rights to Ocular MedicinesEditas Medicine Regains Full Global Rights to Ocular Medicines
finance.yahoo.com - August 6 at 8:03 PM
Editas Medicine Announces Second Quarter 2020 Results and UpdateEditas Medicine Announces Second Quarter 2020 Results and Update
finance.yahoo.com - August 6 at 8:03 PM
Heres Why Shares of Editas Medicine and Beam Therapeutics Are Soaring TodayHere's Why Shares of Editas Medicine and Beam Therapeutics Are Soaring Today
fool.com - August 6 at 3:03 PM
Editas Medicine Q2 2020 Earnings PreviewEditas Medicine Q2 2020 Earnings Preview
seekingalpha.com - August 5 at 6:56 PM
CRISPR Technology Global Market Report 2020-30: Covid 19 Growth and ChangeCRISPR Technology Global Market Report 2020-30: Covid 19 Growth and Change
www.prnewswire.com - July 30 at 7:32 PM
Earnings Preview: Editas Medicine (EDIT) Q2 Earnings Expected to DeclineEarnings Preview: Editas Medicine (EDIT) Q2 Earnings Expected to Decline
finance.yahoo.com - July 30 at 2:29 PM
Editas taps Catalent to supply lineup of productsEditas taps Catalent to supply lineup of products
seekingalpha.com - July 29 at 1:54 PM
Catalent Enters into Strategic Partnership with Editas Medicine to Support Gene Editing Medicine PipelineCatalent Enters into Strategic Partnership with Editas Medicine to Support Gene Editing Medicine Pipeline
finance.yahoo.com - July 29 at 8:53 AM
Editas Medicine Appoints Gad Berdugo as Chief Business OfficerEditas Medicine Appoints Gad Berdugo as Chief Business Officer
finance.yahoo.com - July 27 at 6:09 PM
This page was last updated on 12/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.